Mark Gilreath is a proven healthcare executive with more than 30 years of experience founding, scaling, and leading successful medical technology companies. He previously served as Founding CEO of United Digestive, guiding its growth to
1,500+ employees and a $500M acquisition in 2023, and as Founder and CEO of EndoChoice (NYSE: GI), later acquired by Boston Scientific. Earlier, he helped launch the groundbreaking PillCam Video Capsule while serving as President of The Americas and CMO at Given Imaging. A former U.S. Naval Intelligence Officer, Mark has been recognized as Metro Atlanta’s Business Person of the Year and serves on multiple public and private boards. He holds an MBA from Duke University’s Fuqua School of Business.
Mr. Warlick co-founded our company and is an Initial Member, Manager, former Chief Executive Officer, and current Chief Scientific Officer of our company. Mr. Warlick has been employed in the shockwave industry since 1985.
and was the founder of the first publicly traded company in this field. In 1996, he founded OssaTronics, the predecessor to HealthTronics, a publicly traded healthcare company (Nasdaq:HTRN). From 1996 until mid-2000, Mr. Warlick held various positions as the vice president of HealthTronics and the president of both HealthTronics and OssaTronics. From 1991 until 1996, he was the vice president of sales and then the president and a director of Servicetrends, Inc., the nation’s first third-party lithotripter service company. From 1989 to 1991, he was the vice president of sales for Energy Four, a medical consumables company. From 1985 to 1988 he was the sales operations manager of Dornier Medical Systems. Prior to this Mr. Warlick was employed by Lockheed. Mr. Warlick earned a B.S. in Financial Management from Clemson University.
Tom Rhoads brings more than three decades of leadership in high-growth healthcare and digital technology. He previously led Parata Systems as CEO, launching pharmacy automation platforms that now fill over 430 million prescriptions annually and helping
position the company for a $1.5B acquisition by BD. As Founder and CEO of Spencer Health Solutions, he built a global medication management and telehealth platform supporting clinical trials and at-risk patients across North America and Europe. A Duke University graduate and former scholarship athlete, Tom holds six patents in digital health and an MBA from The Citadel. He is passionate about advancing non-invasive medical innovation that improves lives.
Mr. Tate brings more than 50 years of entrepreneurial experience to the companies in which he is involved. In 1967, he founded Valley Sanitation, a two-truck waste hauling business in Fort Atkinson, Wisconsin. The company employed
three people and generated annual revenues of $40,000 the first year. In 1993, he merged his 12-location business with 10 others to form Superior Services, Inc., a solid waste, special waste and hazardous waste business serving the Midwest. By 1999, Superior had a successful initial public offering, a secondary offering and finally, sold to a French conglomerate, Vivendi. At the time of the sale, Superior had over 3,000 employees. Mr. Tate served as President/CEO and Chairman of the Board at Superior. After the sale of Superior Services, Inc., Mr. Tate started Tate Enterprises, a company offering professional management services to the organizations in which he is a substantial equity partner.
Dr. Schaden is a Manager of our company and Director of TRT’s Scientific Advisory Board. Since 1998, Dr. Schaden has served as the Chief of the Department of Shockwave
Therapy in Meidling Trauma Center in Vienna, Austria. In 1997, he founded the International Society for Musculoskeletal Shockwave Therapy (ISMST) in Vienna. Since 1992, he has been a member of the re-plantation team of Meidling Trauma Center and in 1993 he performed his first treatment with extracorporeal shockwaves on non-union fractures. Since 1988, he has worked in Vienna, Austria’s Meidling Trauma Center Unit, which treats an average of 60,000 patients per year. From 1986-1987, he joined a peace keeping force in Syria for 6 months. Dr. Schaden trained for traumatology in the Clinic of Wiener Neustadt from 1982 to 1986. He has also received special training in Microsurgery, Reconstructive surgery and Neurosurgery. In addition, Dr. Schaden has produced over 40 published articles and given more than 200 presentations in the field of extracorporeal shockwave therapy.
Dr. Mullins is the recent Chairman Department of Surgery at Piedmont Atlanta Hospital and has years of experience dealing with complex injuries and complicated reconstructive surgical cases. He is a leader in the use of SoftWave ESWT treatment for surgical and wound care applications in the U.S.
Dr. Mullins graduated from the Emory School of Medicine. He served in the United States Air Force as a Colonel, State Air Force Surgeon, and then Joint State Surgeon for the Georgia National Guard. He entered his Plastic and Reconstructive Surgery practice in 1985. He holds and has held key level positions including Chairman Department of Surgery, Piedmont Atlanta Hospital, Attending Staff – Piedmont Hospital, and the Shepherd Center. His professional society memberships include:
His professional activities include:
John Finney worked as an executive in healthcare for Johnson and Johnson and he was a recipient of their coveted J&J achievement award for developing a national hospital consulting software program. He was also a consultant for Johnson and Johnson where he was successful in new business development.
John has served as CEO of several start-up companies that he developed and sold in the areas of healthcare.